MediciNova, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

MediciNova, Inc. (NASDAQ: MNOV, TSE: 4875) is a late-stage, global biopharmaceutical company that is developing novel therapeutics with a primary focus on neurodegenerative disorders, beginning with Amyotrophic Lateral Sclerosis (ALS), with a secondary focus on conditions like respiratory and liver disease, fibrotic diseases, acute lung injury, metabolic diseases, and more with high unmet need. MediciNova’s goal is to address the unmet needs many patients are dealing with in these spaces, providing solutions and treatments to further address them while improving quality of life.

Sign up for free to view info

Email Format Employee directory